secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2026-05-15T13:08:56+00:00
Accession:  0001171843-26-003459
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech CEO to receive 90% of salary as RSUs, up from 50%
---------------------------------------------------------------

- CEO Pardeep Nijhawan will receive 90% of monthly base salary as fully vested RSUs, effective May 13, 2026.
- Previously, 50% of base salary was issued as RSUs; remaining 10% paid in cash for withholding and tax requirements.
- RSUs granted each month at month-end fair market value under the 2019 Equity Incentive Compensation Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/0001171843-26-003459-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/f8k_051526.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003459

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer